1. FRI0607 Long-term and optimization of infliximab in refractory uveitis associated to behÇet disease. multicentre study of 100 patients. (15th June 2017) Authors: Casas, LC Domínguez; Calvo-Río, V; Beltrán, E; S-Bursόn, J; Mesquida, M; Adán, A; Hernandez, M; L-Longo, F; H-Grafella, M; Valls, E; M-Costa, L; Sellas, A; G-Serrano, J; Callejas, J; Ortego, N; Herreras, J; Follonosa, A; Maíz, O; Blanco, A; Torre, I Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice. (1st November 2016) Authors: Leon, L; Rodriguez-Rodriguez, L; Rosales, Z; Gomez, A; Lamas, JR; Pato, E; Jover, JA; Abasolo, L Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 6(2016) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0235 Treatment of refractory posterior uveitis with anti-tnf-alfa (infliximab). (1st June 2001) Authors: Banares, A; Pato, E; Abasolo, L; Macarron, P; Hernandez, C; Jover, JA; Fernandez, B Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0326 Short and long-term follow-up with adalimumad in refractory uveitis associated to behÇet's disease. multicenter study of 74 patients. (15th June 2017) Authors: Domínguez-Casas, L; Calvo-Río, V; Beltrán, E; S-Bursόn, J; Mesquida, M; Adán, A; Hernandez, M; H-Grafella, M; V-Pascual, E; M-Costa, L; Sellas, A; Cordero-Coma, M; Díaz-Llopis, M; Gallego, R; Salom, D; G-Serrano, J; Ortego, N; Herreras, J; G-Aparicio, A; Maíz, O Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗